וידאזה - Vidaza
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | L01BC Pyrimidine analogues | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ×ר××× ×¤×¢×× (ATC5) | Â
| ||||||||||||||||||||||||
| צ×רת ××ª× | ת××-×ר×××, תת-×¢××¨× - I.V; S.C | ||||||||||||||||||||||||
| צ×רת ××× ×× | LYOPHILIZED POWDER FOR PREPARATION FOR INJECTION ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× | ||||||||||||||||||||||||
| ×ת×××× | For the treatment of patients with the following FAB myelodysplastic syndromes subtypes: refractory anemia or refractory anemia with ringed sideroblasts ( if accompanied by neutropenia or thrombocytopenia or requiring transfusions),refractory anaemia with excess blasts, refractory anaemia with excess blasts in transformation, and chronic myelomonocytic leukaema.
| ||||||||||||||||||||||||
| |||||||||||||||||||||||||
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
 Â
| ||||||||||||||||||||||||
| ×¢××× ×צר×× |  |
|---|
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| ×××××× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | CELGENE INTERNATIONAL SARL, SWITZERLAND |
| ×©× ××¢× ×ר×ש×× | NEOPHARM LTD |
| ר×ש××× | ת×ר×× ××ש×: 12/2009. ר×ש××× ×ת×ר××: 12/2012 |
| ת×ר×× ×¢×××× ××ר×× | 15/05/19 |
השינוי האחרון נעשה בֹ־27 בדצמבר 2021 ב־21:54